The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index; 114 of the 199 sources its claims cite were checked for support.
Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook
Open accessAbstract
Major depressive disorder (MDD) is a highly prevalent and heterogeneous psychiatric disorder shaped by the interplay of genetic, environmental, and epigenetic factors. Histone modifications, particularly acetylation and methylation, have emerged as critical regulators of chromatin dynamics and gene expression in stress adaptation, neuroplasticity, and emotional regulation. This review synthesizes current evidence linking dysregulated histone deacetylases (HDACs) and histone methyltransferases (HMTs) to impaired neuroplasticity, neuroinflammation, mitochondrial dysfunction, and hypothalamic–pituitary–adrenal (HPA) axis hyperactivity in depression. We further evaluate the therapeutic potential of HDAC and HMT inhibitors, highlight their effects beyond transcriptional control, and discuss peripheral epigenetic biomarkers as candidate tools for patient stratification and treatment prediction. Emerging technologies, including single-cell and spatial epigenomics as well as CRISPR-based epigenetic editing, are outlined as future avenues toward precision medicine. While isoform specificity, off-target effects, and translational heterogeneity remain major challenges, targeting histone modifications represents a promising strategy for next-generation antidepressant development.
Overview
CoChat Summary
TL;DR
This narrative review synthesizes evidence that dysregulated histone acetylation and methylation—chiefly via HDACs and HMTs—contribute to depression pathophysiology through impaired neuroplasticity, neuroinflammation, mitochondrial dysfunction, and HPA-axis hyperactivity, and evaluates HDAC/HMT inhibitors as candidate antidepressants. It concludes that clinical translation remains early-stage, constrained by isoform specificity, off-target effects, and translational heterogeneity.
Key findings
- MDD affects over 280 million individuals globally, with global prevalence rising nearly 50% over the past three decades; histone hypoacetylation at H3K9ac and H4K12ac in hippocampus and prefrontal cortex is associated with reduced BDNF, SLC6A4, CREB, and monoamine-synthesis enzymes (TH, TPH) in chronic stress models.
- The mammalian HDAC family comprises 18 isoforms in four classes (I–IV); Class I and II isoforms appear most relevant to depression, with HDAC2/5 activity increased by chronic stress and HDAC5-mediated H4K12 deacetylation linked to stress vulnerability.
- Repressive methylation marks H3K9me3 (SETDB1) and H3K27me3 (EZH2) silence mood-relevant genes: SETDB1 loss derepresses Htr3a in cortical GABAergic interneurons producing anxiety/depression-like behavior in mice (partially reversed by 5-HT3 antagonists), while EZH2 inhibitors GSK126 and EPZ-6438 (tazemetostat) alleviate depressive-like behavior in preclinical models.
- HDAC inhibitors (SAHA, entinostat) show antidepressant, anti-inflammatory, and metabolic effects in animal models, but direct human evidence in depression is limited and large-scale randomized controlled trials are lacking; SAHA and entinostat have reached phase I/II oncology trials only.
Methods
- Narrative review integrating preclinical (rodent chronic unpredictable stress, chronic social defeat stress, prenatal stress), cellular, and clinical literature on histone modifications in MDD.
- Covers nucleosome biology, writer/eraser/reader enzymology, region- and sex-specific chromatin alterations (PFC, NAc, hippocampus/DG), HDAC/HMT pharmacology, peripheral biomarkers, and emerging technologies (single-cell/spatial epigenomics, CRISPR-dCas9 editing).
- No primary data, systematic search protocol, or meta-analysis is reported.
Limitations
- Stated: HDAC inhibitors display limited isoform selectivity and off-target activity; broad-spectrum inhibition raises systemic and neurocognitive safety concerns; epigenetic drugs act on interconnected networks with compensatory responses; temporal, regional, and cellular heterogeneity complicate prediction; animal models incompletely capture clinical heterogeneity, chronicity, and symptom profiles, with species-specific epigenetic differences; peripheral biomarkers lack multicenter longitudinal validation and their reflection of central pathology is uncertain; clinical evidence in depression remains early-phase.
- Evident from the text: as a narrative review without a stated search strategy or quality appraisal, the synthesis is selective and does not quantify effect sizes or assess risk of bias across cited studies; several mechanistic claims rest on non-depression models (spinal cord injury, UVB photoaging, cellular senescence, Alzheimer's disease).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
80 Valid · 10 Not valid · 42 Not checked · 69 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“HDAC5-mediated H4K12 deacetylation in the hippocampus contributes to stress vulnerability, indicating its value as a potential therapeutic target in susceptible populations (Dai et al., 2023; Li et al., 2024; Ershadi et al., 2021).”
§ Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook > Clinical and translational evidence > Current status of clinical research
What the sources say
- Disputedcites Dai et al., 2023 sourceExperimental — accuracy not yet measured
The Discussion reports that after chronic restraint stress, hippocampal HDAC9 increased while other HDACs did not show significant changes. The paper identifies HDAC9-mediated deacetylation of ANXA2—not HDAC5-mediated H4K12 deacetylation—as its mechanism for depression-like behavior in mice. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Not matchedcites Li et al., 2024
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites Ershadi et al., 2021 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In depression, altered epigenetic patterns have been observed in key genes related to neurodevelopment and neurotransmission, including the serotonin transporter gene (SLC6A4) and brain-derived neurotrophic factor (BDNF) (Jiang et al., 2019; Levy et al., 2018).”
§ Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook > Introduction
What the sources say
- Partly supportedcites Jiang et al., 2019 sourceExperimental — accuracy not yet measured
In “The Associations Between Methylation and Childhood Trauma” (page unavailable), the paper links higher SLC6A4 methylation with worse clinical presentation in major depressive disorder. It also reports altered BDNF methylation after childhood maltreatment and an association between BDNF and depressive symptoms, but does not establish that the BDNF methylation changes were observed in depression. (LLM, conf=0.85)
- Could not verifycites Levy et al., 2018 sourceExperimental — accuracy not yet measured
The Neuroplasticity: definition section mentions epigenetic regulation of genes involved in plasticity, but does not report altered epigenetic patterns in depression. The BDNF section discusses expression levels and a genetic variant, while the Amygdala section discusses a serotonin-transporter promoter variant; neither identifies an epigenetic alteration in BDNF or SLC6A4. Searches for epigenetic, DNA methylation, SLC6A4, and BDNF promoter methylation found no passage establishing the claim. (LLM, conf=0.76)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Histone modifications play a central role in the epigenetic regulation of depression by influencing chromatin structure and transcriptional control (Czarny et al., 2021; Nestler et al., 2016).”
§ Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook > Introduction
What the sources say
- Supportedcites Czarny et al., 2021 source
Section 3, “Histone Modifications,” links histone modifications to gene-expression control and identifies acetylation and methylation as major subjects of depression research. It explains that acetylation and deacetylation alter chromatin condensation and thereby regulate gene expression, while methylation can activate or repress transcription. (LLM, conf=0.93)
- Supportedcites Nestler et al., 2016 source
The Overview of Epigenetic Mechanisms (“Histones”) explains that histone modifications alter chromatin condensation and gene activity. “Histone Modifications in Adult Depression Models” links those modifications to depression-like behavior and changes in gene expression, supporting the paraphrase. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“HDAC inhibitors directly modulate mitochondrial homeostasis.”
§ Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook > Epigenetic therapeutic targets: focus on HDACs and HMTs > HDAC and HMT modulators beyond gene expression
What the sources say
- Partly supportedcites Vizioli et al., 2020 sourceExperimental — accuracy not yet measured
The Results section reports that HDAC inhibitors improve mitochondrial function in senescent cells. The Discussion says the mechanism is unresolved and that indirect mechanisms are possible, so the paper does not establish that the modulation is direct. Page numbers were not provided in the supplied passages. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“HDAC inhibitors modulate inflammatory pathways beyond transcriptional control (Dai et al., 2025).”
§ Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook > Epigenetic therapeutic targets: focus on HDACs and HMTs > HDAC and HMT modulators beyond gene expression
What the sources say
- Partly supportedcites Dai et al., 2025 sourceExperimental — accuracy not yet measured
The Results section (‘SAHA inhibit UVB-induced inflammatory responses in HaCaT cells’) reports reduced phosphorylated NF-κB protein after treatment with SAHA, an HDAC inhibitor. This supports modulation of inflammatory signaling beyond changes in gene expression, but the study examines one inhibitor in UVB-exposed skin cells; it does not establish the claim for HDAC inhibitors generally. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
96 more claims · 36 with their cited sources checked
Create a free account to see all 201 claims and to verify the 2 references still open.
- It may state two separate claims as one. 90
- Probably not a substantial claim. 17
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Neocortical excitation/inhibition balance in information processing and social dysfunction
Yizhar, O., Fenno, L. E., Prigge, M., Schneider, F., Davidson, T. J., O’Shea, D. J., Sohal, V. S., Goshen, I., Finkelstein, J., Paz, J. T., et al. (2011) · Nature · doi:10.1038/nature10360 · Cited by 2,454
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Beurel, E., Toups, M., & Nemeroff, C. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.002 · Cited by 2,136 · cited 1×
“Clinically, MDD is marked by persistent low mood, anhedonia, cognitive impairment, and physical symptoms such as sleep and appetite disturbances (Beurel et al., 2020).”
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866 · cited 1×
“SAHA exemplifies broad-spectrum inhibition (Marks et al., 2001; Duvic et al., 2007), whereas entinostat shows greater class I selectivity (Kiany et al., 2020).”
Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics
Jiang, S., Li, H., Zhang, L., Mu, W., Zhang, Y., Chen, T., Wu, J., Tang, H., Zheng, S., Liu, Y., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae973 · Cited by 1,804
Self-citationStructures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714 · cited 1×
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
Functions of Site-Specific Histone Acetylation and Deacetylation
Shahbazian, M. D., & Grunstein, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052705.162114 · Cited by 1,635
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584 · cited 2×
“The mammalian HDAC family consists of 18 isoforms categorized into four major classes (Classes I–IV) (Zhang et al., 2024; Glozak et al., 2005; Gallinari et al., 2007; Yang and Grégoire, 2005), as summarized in Table 1 (Vanaja et al., 2018; Johnstone, 2002; Gao et al., 2002; Tong et al., 2002;…”
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515 · cited 1×
“…family consists of 18 isoforms categorized into four major classes (Classes I–IV) (Zhang et al., 2024; Glozak et al., 2005; Gallinari et al., 2007; Yang and Grégoire, 2005), as summarized in Table 1 (Vanaja et al., 2018; Johnstone, 2002; Gao et al., 2002; Tong et al., 2002; Hubbert et al., 2002).”
Liu, Q., He, H., Yang, J., Feng, X., Zhao, F., & Lyu, J. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.08.002 · Cited by 1,452
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Autry, A. E., & Monteggia, L. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005108 · Cited by 1,390 · cited 2×
“…FKBP5 hypomethylation with increased expression correlate with depression severity and suicidal ideation (Roy et al., 2017), supporting HPA-axis dysregulation as a key pathological feature and highlighting PBMC methylation as a potential biomarker (Autry and Monteggia, 2012; Monteiro et al., 2017).”
Schultz, D. C., Ayyanathan, K., Negorev, D., Maul, G. G., & Rauscher, F. J. (2002) · Genes & Development · doi:10.1101/gad.973302 · Cited by 1,313
Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes
Clapier, C. R., Iwasa, J., Cairns, B. R., & Peterson, C. L. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.26 · Cited by 1,305
Duvic, M., Talpur, R., Ni, X., Zhang, C., Hazarika, P., Kelly, C., Chiao, J. H., Reilly, J. F., Ricker, J. L., Richon, V. M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-025999 · Cited by 1,141
Histone post-translational modifications - cause and consequence of genome function
Millán-Zambrano, G., Burton, A., Bannister, A. J., & Schneider, R. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00468-7 · Cited by 1,116
Histones: annotating chromatin
Campos, E. I., & Reinberg, D. (2009) · Annual Review of Genetics · doi:10.1146/annurev.genet.032608.103928 · Cited by 852 · cited 1×
“Combinatorial PTM patterns—the so-called “histone code”—are interpreted by reader proteins that recruit effector complexes to regulate chromatin accessibility (Kouzarides, 2007; Campos and Reinberg, 2009).”
Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET
Matsui, T., Leung, D., Miyashita, H., Maksakova, I. A., Miyachi, H., Kimura, H., Tachibana, M., Lorincz, M. C., & Shinkai, Y. (2010) · Nature · doi:10.1038/nature08858 · Cited by 808
Control of protein stability by post-translational modifications
Lee, J. M., Hammarén, H. M., Savitski, M. M., & Baek, S. H. (2023) · Nature Communications · doi:10.1038/s41467-023-35795-8 · Cited by 796
Dompierre, J. P., Godin, J. D., Charrin, B. C., Cordelières, F. P., King, S. J., Humbert, S., & Saudou, F. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0037-07.2007 · Cited by 792
Gao, L., Cueto, M. A., Asselbergs, F., & Atadja, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111871200 · Cited by 744 · cited 1×
“…family consists of 18 isoforms categorized into four major classes (Classes I–IV) (Zhang et al., 2024; Glozak et al., 2005; Gallinari et al., 2007; Yang and Grégoire, 2005), as summarized in Table 1 (Vanaja et al., 2018; Johnstone, 2002; Gao et al., 2002; Tong et al., 2002; Hubbert et al., 2002).”
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678
Multiple roles of HDAC inhibition in neurodegenerative conditions
Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., & Chiu, C.-T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.002 · Cited by 676
Functional annotation of native enhancers with a Cas9–histone demethylase fusion
Kearns, N. A., Pham, H., Tabak, B., Genga, R. M., Silverstein, N. J., Garber, M., & Maehr, R. (2015) · Nature Methods · doi:10.1038/nmeth.3325 · Cited by 656
Molecular mechanisms directing PRC2 recruitment and H3K27 methylation
Laugesen, A., Højfeldt, J. W., & Helin, K. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.03.011 · Cited by 602 · cited 1×
“Within the Polycomb Repressive Complex 2 (PRC2), EZH2 serves as the catalytic subunit responsible for depositing the repressive H3K27me3 mark and silencing target genes (Blackledge et al., 2020; Laugesen et al., 2019).”
Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse
Schroeder, F. A., Lin, C. L., Crusio, W. E., & Akbarian, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.036 · Cited by 541 · cited 1×
“…depression-related models, reduced acetylation at sites such as H3K9ac and H4K12ac has been associated with decreased expression of key mood-regulating genes, including brain-derived neurotrophic factor (BDNF) and the serotonin transporter (SLC6A4) (Covington et al., 2011; Schroeder et al., 2007).”
Karimi, M. M., Goyal, P., Maksakova, I. A., Bilenky, M., Leung, D., Tang, J. X., Shinkai, Y., Mager, D. L., Jones, S., Hirst, M., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.04.004 · Cited by 535
HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
Khan, O., & La Thangue, N. B. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.100 · Cited by 450 · cited 1×
“TSA and SAHA, for example, do not directly inhibit cGAS–STING signaling or p38/mTOR phosphorylation, but instead restore OXPHOS gene expression and reduce mitochondrial ROS, thereby suppressing CCF and SASP (Vizioli et al., 2020; Khan and La Thangue, 2012; Venkataramani et al., 2010).”
SnapShot: histone modifications
Huang, H., Sabari, B. R., Garcia, B. A., Allis, C. D., & Zhao, Y. (2014) · Cell · doi:10.1016/j.cell.2014.09.037 · Cited by 439 · cited 1×
“Histone proteins undergo multiple post-translational modifications (PTMs) that regulate chromatin structure and gene expression (Huang et al., 2014).”
Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication
Yang, X.-J., & Grégoire, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.2873-2884.2005 · Cited by 419
Epigenetics of the depressed brain: role of histone acetylation and methylation
Sun, H., Kennedy, P. J., & Nestler, E. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.73 · Cited by 413
Vizioli, M. G., Liu, T., Miller, K. N., Robertson, N. A., Gilroy, K., Lagnado, A. B., Perez-Garcia, A., Kiourtis, C., Dasgupta, N., Lei, X., et al. (2020) · Genes & Development · doi:10.1101/gad.331272.119 · Cited by 359 · cited 15×
“TSA and SAHA, for example, do not directly inhibit cGAS–STING signaling or p38/mTOR phosphorylation, but instead restore OXPHOS gene expression and reduce mitochondrial ROS, thereby suppressing CCF and SASP (Vizioli et al., 2020; Khan and La Thangue, 2012; Venkataramani et al., 2010).”
InfluentialProtein lactylation induced by neural excitation
Hagihara, H., Shoji, H., Otabi, H., Toyoda, A., Katoh, K., Namihira, M., & Miyakawa, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109820 · Cited by 349
Epigenetic basis of mental illness
Nestler, E. J., Peña, C. J., Kundakovic, M., Mitchell, A., & Akbarian, S. (2016) · The Neuroscientist · doi:10.1177/1073858415608147 · Cited by 342 · cited 1×
“Histone modifications play a central role in the epigenetic regulation of depression by influencing chromatin structure and transcriptional control (Czarny et al., 2021; Nestler et al., 2016).”
Chen, S., Ye, J., Chen, X., Shi, J., Wu, W., Lin, W., Lin, W., Li, Y., Fu, H., & Li, S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1193-6 · Cited by 315
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
Wei, W., Liu, X., Chen, J., Gao, S., Lu, L., Zhang, H., Ding, G., Wang, Z., Chen, Z., Shi, T., et al. (2017) · Cell Research · doi:10.1038/cr.2017.68 · Cited by 304 · cited 1×
“In addition to removing acetyl groups, HDACs regulate several other lysine acylations—including depropionylation, demyristoylation, and desuccinylation—which contribute to transcriptional control, metabolic regulation, and cellular stress responses (Wei et al., 2017).”
Self-citationThe relationship between chronotype and depressive symptoms: a meta-analysis
Au, J., & Reece, J. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.04.021 · Cited by 297
Activation of the hypothalamic-pituitary-adrenal stress axis induces cellular oxidative stress
Spiers, J. G., Chen, H.-J. C., Sernia, C., & Lavidis, N. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00456 · Cited by 292
Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma
Jiang, S., Postovit, L., Cattaneo, A., Binder, E. B., & Aitchison, K. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00808 · Cited by 288
Epigenetic Mechanisms of Depression and Antidepressant Action
Vialou, V., Feng, J., Robison, A. J., & Nestler, E. J. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134540 · Cited by 277
Methods for ChIP-seq analysis: A practical workflow and advanced applications
Nakato, R., & Sakata, T. (2021) · Methods · doi:10.1016/j.ymeth.2020.03.005 · Cited by 267 · cited 1×
“ChIP-seq reveals genome-wide distributions of histone modifications and regulatory elements (Nakato and Sakata, 2021), whereas ATAC-seq detects chromatin accessibility changes associated with stress or disease states (Wang et al., 2025).”
Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing
Li, K., Liu, Y., Cao, H., Zhang, Y., Gu, Z., Liu, X., Yu, A., Kaphle, P., Dickerson, K. E., Ni, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14362-5 · Cited by 251
Self-citationYuan, M., Yang, B., Rothschild, G., Mann, J. J., Sanford, L. D., Tang, X., Huang, C., Wang, C., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01519-z · Cited by 246
PRC1 catalytic activity is central to polycomb system function
Blackledge, N. P., Fursova, N. A., Kelley, J. R., Huseyin, M. K., Feldmann, A., & Klose, R. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.001 · Cited by 243
Jagadeesh, K. A., Dey, K. K., Montoro, D. T., Mohan, R., Gazal, S., Engreitz, J. M., Xavier, R. J., Price, A. L., & Regev, A. (2022) · Nature Genetics · doi:10.1038/s41588-022-01187-9 · Cited by 239
Mangione (2022) · doi:10.1001/jama.2022.16946 · Cited by 239
Self-citationPu, J., Liu, Y., Zhang, H., Tian, L., Gui, S., Yu, Y., Chen, X., Chen, Y., Yang, L., Ran, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0645-4 · Cited by 230
Kumar, V., Kundu, S., Singh, A., & Singh, S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x19666210609160017 · Cited by 210
Association between maternal and amniotic fluid cortisol is moderated by maternal anxiety
Glover, V., Bergman, K., Sarkar, P., & O’Connor, T. G. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.005 · Cited by 209 · cited 1×
“…stress produces affective abnormalities together with HPA axis hyperactivity and epigenetic disruptions, illustrating the interplay between inflammation, endocrine function, and chromatin regulation in stress vulnerability (Possamai-Della et al., 2023; Glover et al., 2009; Spiers et al., 2014).”
Spinal muscular atrophy: mechanisms and therapeutic strategies
Lorson, C. L., Rindt, H., & Shababi, M. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq147 · Cited by 209 · cited 1×
“Excessive HDAC2 activity is linked to reduced BDNF/c-fos expression and impaired learning and memory (Sun et al., 2019; Lorson et al., 2010), while aberrant HDAC3 expression increases neuronal vulnerability (Kumar et al., 2022).”
Jha, M. K., Minhajuddin, A., Gadad, B. S., Greer, T., Grannemann, B., Soyombo, A., Mayes, T. L., Rush, A. J., & Trivedi, M. H. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.023 · Cited by 206
Tong, J. J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.5.1114 · Cited by 181
Hippocampal-dependent antidepressant-like activity of histone deacetylase inhibition
Covington, H. E., Vialou, V. F., LaPlant, Q., Ohnishi, Y. N., & Nestler, E. J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.02.022 · Cited by 178
Cancers with wrong HATs: the impact of acetylation
Di Cerbo, V., & Schneider, R. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/els065 · Cited by 178
Histone deacetylase 11 is a fatty-acid deacylase
Kutil, Z., Novakova, Z., Meleshin, M., Mikesova, J., Schutkowski, M., & Barinka, C. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00942 · Cited by 174
Epigenetic signaling in psychiatric disorders: stress and depression
Bagot, R. C., Labonté, B., Peña, C. J., & Nestler, E. J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/rbagot · Cited by 171 · cited 1×
“Prenatal stress simultaneously elevates DNMT activity and alters H3 acetylation, alongside increased HPA axis reactivity (Possamai-Della et al., 2023), indicating functional interactions between DNA methylation and metabolic/stress pathways (Bagot et al., 2014; Sun et al., 2013).”
C-Reactive protein as a biomarker for major depressive disorder?
Orsolini, L., Pompili, S., Tempia Valenta, S., Salvi, V., & Volpe, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031616 · Cited by 171
Amini-Khoei, H., Mohammadi-Asl, A., Amiri, S., Hosseini, M.-J., Momeny, M., Hassanipour, M., Rastegar, M., Haj-Mirzaian, A., Mirzaian, A. H., Sanjarimoghaddam, H., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.02.022 · Cited by 153
Histone deacetylase 11 is an ε-N-Myristoyllysine hydrolase
Moreno-Yruela, C., Galleano, I., Madsen, A. S., & Olsen, C. A. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.04.007 · Cited by 149
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
Verma, A., Singh, A., Singh, M. P., Nengroo, M. A., Saini, K. K., Satrusal, S. R., Khan, M. A., Chaturvedi, P., Sinha, A., Meena, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35059-x · Cited by 148
Histone acetylation regulates chromatin accessibility: Role of H4K16 in inter-nucleosome interaction
Zhang, R., Erler, J., & Langowski, J. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2016.11.015 · Cited by 142
Roy, B., Shelton, R. C., & Dwivedi, Y. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.02.005 · Cited by 139
Kelly, R. D. W., Chandru, A., Watson, P. J., Song, Y., Blades, M., Robertson, N. S., Jamieson, A. G., Schwabe, J. W. R., & Cowley, S. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-32927-9 · Cited by 138
Venkataramani, V., Rossner, C., Iffland, L., Schweyer, S., Tamboli, I. Y., Walter, J., Wirths, O., & Bayer, T. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057836 · Cited by 133
Sun, X., Sun, J., Lu, X., Dong, Q., Zhang, L., Wang, W., Liu, J., Ma, Q., Wang, X., Wei, D., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.05.021 · Cited by 129
Self-citationFagiolini, A., Florea, I., Loft, H., & Christensen, M. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.11.106 · Cited by 127
Carleton, J. B., Berrett, K. C., & Gertz, J. (2017) · Cell Systems · doi:10.1016/j.cels.2017.08.011 · Cited by 125
Zheng, Y., Fan, W., Zhang, X., & Dong, E. (2016) · Epigenetics · doi:10.1080/15592294.2016.1146850 · Cited by 111
Bibliometric Analysis of the Inflammasome and Pyroptosis in Brain
Chen, Y., Li, Y., Guo, L., Hong, J. Y., Zhao, W., Hu, X., Chang, C., Liu, W., & Xiong, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.626502 · Cited by 109
Neuroprotection by histone deacetylase-related protein
Morrison, B. E., Majdzadeh, N., Zhang, X., Lyles, A., Bassel-Duby, R., Olson, E. N., & D'Mello, S. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3550-3564.2006 · Cited by 100
Antidepressant action of HDAC inhibition in the prefrontal cortex
Covington, H. E., Maze, I., Vialou, V., & Nestler, E. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.030 · Cited by 97
The Mbd1-Atf7ip-Setdb1 pathway contributes to the maintenance of X chromosome inactivation
Minkovsky, A., Sahakyan, A., Rankin-Gee, E., Bonora, G., Patel, S., & Plath, K. (2014) · Epigenetics & Chromatin · doi:10.1186/1756-8935-7-12 · Cited by 91
Athira, K. V., Madhana, R. M., Indu Chandran, J. S., Lahkar, M., Sinha, S., & Naidu, V. G. M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.009 · Cited by 90
Meylan, E. M., Halfon, O., Magistretti, P. J., & Cardinaux, J.-R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.012 · Cited by 87
Suh, H.-S., Choi, S., Khattar, P., Choi, N., & Lee, S. C. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9192-0 · Cited by 86
Yao, Y., Bade, R., Li, G., Zhang, A., Zhao, H., Fan, L., Zhu, R., & Yuan, J. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01277-6 · Cited by 86 · cited 1×
“Recent findings indicate that lactate-associated lactylation modulates glial inflammatory states and neuronal synaptic function, supporting its role in neuroplasticity (Yao et al., 2023; Hagihara et al., 2021).”
Zhou, H., Cai, Y., Liu, D., Li, M., Sha, Y., Zhang, W., Wang, K., Gong, J., Tang, N., Huang, A., et al. (2018) · Cell Proliferation · doi:10.1111/cpr.12447 · Cited by 85
Role of histone deacetylases and their inhibitors in neurological diseases
Zhang, L.-Y., Zhang, S.-Y., Wen, R., Zhang, T.-N., & Yang, N. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107410 · Cited by 84
Sadeghi, M., Peeri, M., & Hosseini, M.-J. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.05.017 · Cited by 83
Vanaja, G. R., Ramulu, H. G., & Kalle, A. M. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0231-4 · Cited by 82 · cited 1×
“…family consists of 18 isoforms categorized into four major classes (Classes I–IV) (Zhang et al., 2024; Glozak et al., 2005; Gallinari et al., 2007; Yang and Grégoire, 2005), as summarized in Table 1 (Vanaja et al., 2018; Johnstone, 2002; Gao et al., 2002; Tong et al., 2002; Hubbert et al., 2002).”
Bahl, S., & Seto, E. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03599-4 · Cited by 82 · cited 1×
“Histone deacetylases (HDACs), which function as key “erasers” of acetyl marks, are classified into five groups—Class I, Class IIa, Class IIb, Class III (sirtuins), and Class IV—based on sequence homology, subcellular localization, and cofactor dependence (Bahl et al., 2021; Bahl and Seto, 2021).”
Genetic and epigenetic factors associated with depression: an updated overview
Alshaya, D. S. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.103311 · Cited by 81 · cited 1×
“Traditional genetic studies have identified heritable components of major depressive disorder (MDD), but they only partially account for its heterogeneity and sensitivity to environmental influences (Alshaya, 2022).”
Wu, J., Li, Y., Huang, Y., Liu, L., Zhang, H., Nagy, C., Tan, X., Cheng, K., Liu, Y., Pu, J., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01379-4 · Cited by 77
Jin-hong, H., Yao, W., Chang, S., You, L., Zhao, M., Cheung, P. C. K., & Hileuskaya, K. S. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111267 · Cited by 76
Monteiro, B. C., Monteiro, S., Candida, M., Adler, N., Paes, F., Rocha, N., Nardi, A. E., Murillo-Rodriguez, E., & Machado, S. (2017) · Clinical Practice & Epidemiology in Mental Health · doi:10.2174/1745017901713010213 · Cited by 63
Baretti, M., Danilova, L., Durham, J. N., Betts, C. B., Cope, L., Sidiropoulos, D. N., Tandurella, J. A., Charmsaz, S., Groß, N., Hernandez, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52528-7 · Cited by 63
Tyler, C. R., Hafez, A. K., Solomon, E. R., & Allan, A. M. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.07.013 · Cited by 60
Chen, W.-Y., Zhang, H., Gatta, E., Glover, E. J., Pandey, S. C., & Lasek, A. W. (2019) · Alcohol · doi:10.1016/j.alcohol.2019.02.005 · Cited by 59
Sun, X.-Y., Zheng, T., Yang, X., Liu, L., Gao, S.-S., Xu, H.-B., Song, Y.-T., Tong, K., Yang, L., Gao, Y., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1640-z · Cited by 59
Amiri, S., Haj-Mirzaian, A., Momeny, M., Amini-Khoei, H., Rahimi-Balaei, M., Poursaman, S., Rastegar, M., Nikoui, V., Mokhtari, T., Ghazi-Khansari, M., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.11.003 · Cited by 58
MicroRNAs as critical biomarkers of major depressive disorder: a comprehensive perspective
Ortega, M. A., Alvarez-Mon, M. A., García-Montero, C., Fraile-Martinez, O., Lahera, G., Monserrat, J., Muñoz-Merida, L., Mora, F., Rodríguez-Jiménez, R., Fernandez-Rojo, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9111659 · Cited by 57 · cited 1×
“Dysregulated microRNA expression is also linked to synaptic plasticity, neuroinflammation, and stress response (Ortega et al., 2021; Elhag and Al Khodor, 2023).”
Cell-type-specific genomics reveals histone modification dynamics in mammalian meiosis
Lam, K.-W. G., Brick, K., Cheng, G., Pratto, F., & Camerini‐Otero, R. D. (2019) · Nature Communications · doi:10.1038/s41467-019-11820-7 · Cited by 56 · cited 1×
“…acetylation, methylation, phosphorylation, and ubiquitination, forming combinatorial patterns often referred to as the “histone code,” which influences transcription in a context-dependent manner (Millán-Zambrano et al., 2022; Miziak et al., 2024; Jenuwein and Allis, 2001; Lam et al., 2019).”
Zhou, J., Li, M., Wang, X., He, Y., Xia, Y., Sweeney, J. A., Kopp, R. F., Liu, C., & Chen, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.674273 · Cited by 56 · cited 1×
“…genes such as BDNF, SLC6A4, NR3C1, and FKBP5 have been associated with antidepressant efficacy in major depressive disorder, while comparable patterns have also been reported in bipolar disorder and schizophrenia, supporting their potential utility as transdiagnostic biomarkers (Zhou et al., 2021).”
Diurnal preference and depressive symptomatology: a meta-analysis
Norbury, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-91205-3 · Cited by 56 · cited 1×
“…as the DunedinPACE clock indicate that depressive symptoms—particularly in women—are associated with faster biological aging, suggesting that peripheral methylation may reflect not only illness severity but also chronicity and recurrence risk (Sorlí et al., 2024; Norbury, 2021; Au and Reece, 2017).”
Kim, S. S., Truong, B., Jagadeesh, K., Dey, K. K., Shen, A. Z., Raychaudhuri, S., Kellis, M., & Price, A. L. (2024) · Nature Communications · doi:10.1038/s41467-024-44742-0 · Cited by 56
HDACs and the epigenetic plasticity of cancer cells: target the complexity
Brancolini, C., Gagliano, T., & Minisini, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108190 · Cited by 55
Liu, D., Qiu, H.-M., Fei, H.-Z., Hu, X.-Y., Xia, H.-J., Wang, L.-J., Qin, L.-J., Jiang, X.-H., & Zhou, Q.-X. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370213513987 · Cited by 49
The role of histone deacetylase 6 in synaptic plasticity and memory
Perry, S., Kiragasi, B., Dickman, D., & Ray, A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.028 · Cited by 49 · cited 1×
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
Zhao, J., Niu, C., Wang, J., Yang, H., Du, Y., Wei, L., & Li, C. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s151107 · Cited by 49
Acetylation of histone H3 in cancer progression and prognosis
Miziak, P., Baran, M., Borkiewicz, L., Trombik, T., & Stepulak, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010982 · Cited by 49 · cited 1×
“…acetylation, methylation, phosphorylation, and ubiquitination, forming combinatorial patterns often referred to as the “histone code,” which influences transcription in a context-dependent manner (Millán-Zambrano et al., 2022; Miziak et al., 2024; Jenuwein and Allis, 2001; Lam et al., 2019).”
Histone H3 phosphorylation near the nucleosome dyad alters chromatin structure
North, J. A., Šimon, M., Ferdinand, M. B., Shoffner, M. A., Picking, J. W., Howard, C. J., Mooney, A. M., van Noort, J., Poirier, M. G., & Ottesen, J. J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku150 · Cited by 46 · cited 1×
“While the histone core contributes to nucleosome stability, the flexible N-terminal tails undergo reversible modifications that alter histone–DNA interactions and shift chromatin between active and repressive states (North et al., 2014).”
Microglial PCGF1 alleviates neuroinflammation associated depressive behavior in adolescent mice
Li, N., Du, J., Yang, Y., Zhao, T., Wu, D., Peng, F., Wang, D., Kong, L., Zhou, W., & Hao, A. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02714-2 · Cited by 46 · cited 4×
“Epigenetic alterations mediated by H3K27me3 (EZH2) and H3K9me3 (SETDB1) are not unique to depression but also appear in models of schizophrenia and bipolar disorder (Li et al., 2025; Li et al., 2023).”
InfluentialPoziello, A., Nebbioso, A., Stunnenberg, H. G., Martens, J. H. A., Carafa, V., & Altucci, L. (2021) · Epigenetics · doi:10.1080/15592294.2020.1827723 · Cited by 44
EGFR phosphorylates HDAC1 to regulate its expression and anti-apoptotic function
Bahl, S., Ling, H., Acharige, N. P. N., Santos‐Barriopedro, I., Pflum, M. K. H., & Seto, E. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03697-6 · Cited by 42
Singh, G., Singh, V., & Schneider, J. S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.016 · Cited by 39
Zhang, Y., Li, G., Liu, C., Guan, J., Zhang, Y., & Shi, Z. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1199510 · Cited by 38
The importance of epigenetics in diagnostics and treatment of major depressive disorder
Czarny, P., Białek, K., Ziółkowska, S., Strycharz, J., Barszczewska, G., & Sliwinski, T. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030167 · Cited by 37
Lei, Z., Mozaffaritabar, S., Kawamura, T., Koike, A., Kolonics, A., Kéringer, J., Pinho, R. A., Sun, J., Shangguan, R., & Radák, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24421 · Cited by 36 · cited 1×
“Physical activity, which elevates systemic lactate levels, may therefore influence neuronal gene expression partially through histone lactylation (Lei et al., 2024).”
Sáez, J. E., Gómez, A. V., Barrios, Á. P., Parada, G. E., Galdames, L., González, M., & Andrés, M. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131760 · Cited by 33
Deciphering Depression: Epigenetic Mechanisms and Treatment Strategies
Aljabali, A. A. A., Alkaraki, A. K., Gammoh, O., Tambuwala, M. M., Mishra, V. K., Mishra, Y., Hassan, S. S., & El‐Tanani, M. (2024) · Biology · doi:10.3390/biology13080638 · Cited by 33
Dang, S., Lu, Y., Su, Q., Lin, T., Zhang, X., Zhang, H., Zhang, J., Zhang, L., Zhu, Z., & Li, H. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.043 · Cited by 30
Ribeiro, A. C. R., Jahr, F. M., Hawkins, E., Kronfol, M. M., Younis, R. M., McClay, J. L., & Deshpande, L. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119765 · Cited by 30
Wu, P., Kong, L., Zhou, Y., Deng, C., Wang, Z., Shen, Y., Wang, L. A., Tuo, Z., Liu, Y., Wang, Y., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03133-7 · Cited by 29
Self-citationErshadi, A. S. B., Amini-Khoei, H., Hosseini, M.-J., & Dehpour, A. R. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03263-8 · Cited by 25
The histone deacetylase inhibitor entinostat/syndax 275 in osteosarcoma
Kiany, S., Harrison, D., & Gordon, N. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43032-0_7 · Cited by 24 · cited 1×
“SAHA exemplifies broad-spectrum inhibition (Marks et al., 2001; Duvic et al., 2007), whereas entinostat shows greater class I selectivity (Kiany et al., 2020).”
The molecular basis of depression: implications of sex-related differences in epigenetic regulation
Kawatake-Kuno, A., Murai, T., & Uchida, S. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.708004 · Cited by 23
Inflammatory markers and incident depression: evidence in a population-based prospective study
Shi, R., Gwee, X., Chua, D. Q., Tan, C. T., Yap, K. B., Larbi, A., Lu, Y., & Ng, T. P. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105806 · Cited by 23
The NuRD complex in neurodevelopment and disease: a case of sliding doors
Boulasiki, P., Tan, X. W., Spinelli, M., & Riccio, A. (2023) · Cells · doi:10.3390/cells12081179 · Cited by 22 · cited 1×
“Through this regulatory mechanism, HDACs modulate key neurobiological processes, including neuronal differentiation, synaptic plasticity, learning, and memory formation (Boulasiki et al., 2023; Clapier et al., 2017).”
Dai, Y., Wei, T., Huang, Y., Bei, Y., Lin, H., Shen, Z., Yu, L., Yang, M., Xu, H., He, W., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04945-y · Cited by 22
Li, J., Zheng, S., Dong, Y., Xu, H., Zhu, Y., Weng, J., Sun, D., Wang, S., Xiao, L., & Jiang, Y. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.08.021 · Cited by 20
Self-citationExploring the potential of microRNA as a diagnostic tool for gestational diabetes
Elhag, D. A., & Al Khodor, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04269-2 · Cited by 20 · cited 1×
“Dysregulated microRNA expression is also linked to synaptic plasticity, neuroinflammation, and stress response (Ortega et al., 2021; Elhag and Al Khodor, 2023).”
Sun, Z., Zhang, B., Zhou, J., Luo, Y., Zhu, X., Wang, Y., He, Y., Zheng, P., Zhang, L., Yang, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202308393 · Cited by 20
Dai, C., Liu, B., Peng, B., Qu, B., Lin, J., Peng, B., & Li, D.-M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.774539 · Cited by 19
Milic, J., Jovic, S., & Sapic, R. (2025) · Genes · doi:10.3390/genes16050487 · Cited by 19
Li, H., Jiang, Q., Fu, X., Jiang, X., Zhou, Q., & Qiu, H. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000879 · Cited by 18
Chen, G., Zhou, Z., Sha, W., Wang, L., Yan, F., Yang, X., Qin, X., Wu, M., Li, D., Tian, S., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4509 · Cited by 18
Pan, Y., Luo, R., Zhang, S., Liu, Y., Wang, Y., Feng, S., & Li, H. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.080 · Cited by 18
Association of histone modification with the development of schizophrenia
Chen, Y.-Z., Zhu, X.-M., Lv, P., Hou, X.-K., Pan, Y., Li, A., Du, Z., Xuan, J.-F., Guo, X., Xing, J.-X., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116747 · Cited by 18 · cited 1×
“Chromatin remodeling plays a critical role in regulating gene expression, with post-translational modifications (PTMs) on histone tails serving as key modulators of nucleosome dynamics (Chen et al., 2024).”
Novel histone acetyltransferase (HAT) inhibitors for treating diseases
Sabnis, R. W. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00337 · Cited by 17 · cited 1×
“Major HAT families include GNAT, p300/CBP, MYST, and Rtt109 (Poziello et al., 2021; Sabnis, 2021; Di Cerbo and Schneider, 2013).”
Thapa Magar, T. B., Mallik, S. K., Gurung, P., Lim, J., Kim, Y.-T., Shrestha, R., & Kim, Y.-W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713468 · Cited by 17
Vorinostat attenuates UVB-induced skin senescence by modulating NF-κB and mTOR signaling pathways
Dai, Q., Wang, Z., Wang, X., Lian, W., Ge, Y., Song, S., Li, F., Zhao, B., Li, L., Wang, X., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-95624-4 · Cited by 17
Self-citationPossamai-Della, T., Cararo, J. H., Aguiar-Geraldo, J. M., Peper-Nascimento, J., Zugno, A. I., Fries, G. R., Quevedo, J., & Valvassori, S. S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03348-1 · Cited by 16
Epigenetic modifications and obsessive–compulsive disorder: what do we know?
Mohammadi, A. H., Karimian, M., Mirzaei, H., & Milajerdi, A. (2023) · Brain Structure and Function · doi:10.1007/s00429-023-02649-4 · Cited by 14 · cited 1×
“Epigenetics refers to heritable but reversible modifications in gene expression that occur without changes to the DNA sequence, primarily through mechanisms such as DNA methylation, histone modification, and non-coding RNA regulation (Aljabali et al., 2024; Mohammadi et al., 2023).”
Schiele, M. A., Crespo Salvador, O., Lipovsek, J., Schwarte, K., Schlosser, P., Zwanzger, P., Arolt, V., Baune, B. T., Köttgen, A., & Domschke, K. (2024) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae045 · Cited by 13
Involvement of 5-HT1A receptor-mediated histone acetylation in the regulation of depression
Zhu, L.-J., Sun, Y.-Q., Wang, S., Shi, H.-J., & Li, N. (2021) · Neuroreport · doi:10.1097/wnr.0000000000001693 · Cited by 12
Wang, N., Zhu, S., Chen, S., Zou, J., Zeng, P., & Tan, S. (2025) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0147 · Cited by 12
Li, N., Liu, T., Wang, Y.-Y., Xu, T., Shi, H., Chang, L., & Zhu, L. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.08.010 · Cited by 11
Molecular programs underlying differences in the expression of mood disorders in males and females
Mena, F., & Benoit, L. (2019) · Brain Research · doi:10.1016/j.brainres.2019.05.016 · Cited by 9
Yadav, A., Dogra, S., Boda, A. K., Kumari, P., Kumar, A., Dash, M. K., & Yadav, P. N. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00175 · Cited by 9
Sorlí, J. V., de la Cámara, E., Fernández-Carrión, R., Asensio, E. M., Portolés, O., Ortega-Azorín, C., Pérez-Fidalgo, A., Villamil, L. V., Fitó, M., Barragán, R., et al. (2024) · Nutrients · doi:10.3390/nu17010104 · Cited by 9
Li, J., Yan, D., Ma, N., Chen, J., Zhao, X., Zhang, Y., & Zhang, C. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01458-x · Cited by 8
Self-citationNasehi, L., Morassaei, B., Ghaffari, M., Sharafi, A., Dehpour, A. R., & Hosseini, M.-J. (2022) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2022-0098 · Cited by 5
Epigenomic profiling of mouse nucleus accumbens at single-cell resolution
Bhatia, P., Yang, L., Luo, J. X. J., Xu, M., & Renthal, W. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103857 · Cited by 5 · cited 1×
“For example, single-cell multi-omics profiling of the nucleus accumbens has delineated depression-relevant cell populations and regulatory elements, providing cell-resolved evidence that may inform target prioritization and mechanistic stratification (Bhatia et al., 2023).”
Cognition and mood-related behaviors in L3mbtl1 null mutant mice
Shen, E. Y., Jiang, Y., Mao, W., Futai, K., Hock, H., & Akbarian, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121252 · Cited by 4
Nucleosome proteostasis and histone turnover
Arrieta, A., & Vondriska, T. M. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.990006 · Cited by 4 · cited 1×
“The nucleosome, the fundamental unit of chromatin, consists of ~147 base pairs of DNA wrapped around a histone octamer composed of H2A, H2B, H3, and H4 (Arrieta and Vondriska, 2022).”
Research works printed but not linked: 1
- 2025, Depressive disorder (depression)
Cited by
Epigenetic regulation in hypertension: mechanistic insights and environmental influences
Perla, S., Goud, A. C., Liu, M., Misra, S., Kumar, A., Srinivasamurthy, S. K., Samara, V. A., Nair, S., & Jain, S. (2026) · American Journal of Hypertension · doi:10.1093/ajh/hpag037
Chakraborty, W., Anand, A., & Roy, K. K. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111846
Epigenetic Control of Stress-Induced Depression: Emerging Roles of HDAC3 and HDAC6
Mohan, A. S., Narayanan, J., Kashid, V. A., Patel, R. J., & Prajapati, B. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167313
“Changes in histone modifications have also been linked to neuroinflammation and neuronal injury in depression [7].”
Genetic, Epigenetic, and Environmental Contributions to Major Depressive Disorder Etiology
Kardan, R., Momeni, A., Shahreza, P. B., & Bayat, H. (2026) · IGI Global eBooks · doi:10.4018/979-8-2600-4270-0.ch001
Recent Advances in Autism Spectrum Disorder Research on Epigenetics and Personalised Medicine
Khosrofar, R., Morshedi, I., Behzadpour, M., Afzali, N., Hosseini, R. S., & Aghili, A. (2026) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.70184
Metadata
- Authors
- Lv, L.-Z., Wang, Z.-D., Ren, J.-J., Li, L.-H., Liu, X.-B., Li, J.-L., Zhu, H., Jiang, B., Han, Y.-P., Zhou, X.-M., Ren, L., & Chang, Z.
- Affiliations
- Heilongjiang University of Chinese Medicine (CN)
- Zhejiang Chinese Medical University (CN)
- Guangdong Medical College (CN)
- Corresponding author
- Chang, Zhuo
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2026-01-12
- Volume
- 16
- Pages
- 1722453-1722453
- ISSN
- 1664-8021 (ISSN-L)
- PMC
- PMC12832117
- OpenAlex
- W7122721022
- Cited by
- 7
- References
- 147
- Citations by year
- 2026: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Genetics (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82205163, 82174421)
- Natural Science Foundation of Heilongjiang Province (PL2024H220)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- histone modifications, major depressive disorder, histone deacetylase, histone methyltransferase, histone deacetylase inhibitors, epigenetic biomarkers, neuroplasticity, neuroinflammation, mitochondrial dysfunction, HPA axis hyperactivity, stress adaptation, emotion regulation, antidepressant drug development, precision medicine, spatial epigenomics, chromatin dynamics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.